EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of CO 2 removal rate of ECCO 2 R for a renal replacement therapy platform in an experimental setting

Zhicheng Qian, Hao He, Yuxuan Wang, Shike Geng, Yang Li, Xueyan Yuan, Rui Zhang, Yi Yang, Haibo Qiu, Songqiao Liu, Ling Liu iD

Artificial Organs · 2024

DOI: 10.1111/aor.14718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2024. Verfasst von Zhicheng Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast Un…. Hauptthemen laut MEDLINE: Carbon Dioxide, Hypercapnia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Clinical Science and Technology Specific Projects of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A critical parameter of extracorporeal CO 2 removal (ECCO 2 R) applications is the CO 2 removal rate (VCO 2 ). Low‐flow venovenous extracorporeal support with large‐size membrane lung remains undefined. This study aimed to evaluate the VCO 2 of a low‐flow ECCO 2 R with large‐size membrane lung using a renal replacement therapy platform in an experimental animal model.

Methods

Twelve healthy pigs were placed under mechanical ventilation and connected to an ECCO 2 R‐CRRT system (surface area = 1.8 m 2 ; OMNIset®, BBraun, Germany). Respiratory settings were reduced to induce two degrees of hypercapnia. VCO 2 was recorded under different combinations of PaCO 2 (50–69 or 70–89 mm Hg), extracorporeal blood flow (ECBF; 200 or 350 mL/min), and gas flow (4, 6, or 10 L/min).

Results

VCO 2 increased with ECBF at all three gas flow rates. In severe hypercapnia, the increase in sweep gas flow from 4 to 10 L/min increased VCO 2 from 86.38 ± 7.08 to 96.50 ± 8.71 mL/min at an ECBF of 350 mL/min, whereas at ECBF of 200 mL/min, any increase was less effective. But in mild hypercapnia, the increase in sweep gas flow result in significantly increased VCO 2 at two ECBF. VCO 2 increased with PaCO 2 from 50–69 to 70–89 mm Hg at an ECBF of 350 mL/min, but not at ECBF of 200 mL/min. Post‐membrane lung PCO 2 levels were similar for different levels of premembrane lung PCO 2 ( p = 0.08), highlighting the gas exchange diffusion efficacy of the membrane lung in gas exchange diffusion. In severe hypercapnia, the reduction of PaCO 2 elevated from 11.5% to 19.6% with ECBF increase only at a high gas flow of 10 L/min ( p < 0.05) and increase of gas flow significantly reduced PaCO 2 only at a high ECBF of 350 mL/min ( p < 0.05).

Conclusions

Low‐flow venovenous extracorporeal ECCO 2 R‐CRRT with large‐size membrane lung is more efficient with the increase of ECBF, sweep gas flow rate, and the degree of hypercapnia. The influence of sweep gas flow on VCO 2 depends on the ECBF and degree of hypercapnia. Higher ECBF and gas flow should be chosen to reverse severe hypercapnia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon DioxideHypercapniaAnimalsSwineExtracorporeal Membrane OxygenationRenal Replacement TherapyRespiration, ArtificialExtracorporeal CirculationLung

Stichwörter der Autor:innen

extracorporeal blood flowextracorporeal carbon dioxide removalgas flow ratehypercapnia

Substanzen

Carbon Dioxide

Autor:innen und Institutionen

  • Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • Department of Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.

ORCID-Profile: Ling Liu

Förderung

  • National Key R&D Program of China
  • Clinical Science and Technology Specific Projects of Jiangsu Province
  • National Natural Science Foundation of China
  • Second Level Talents of the "333 High Level Talents Training Project" in the sixth phase in Jiangsu
  • Jiangsu Provincial Medical Key Laboratory
  • BBraun

Zitieren

APA

Qian, Z., He, H., Wang, Y., Geng, S., Li, Y., Yuan, X., Zhang, R., Yang, Y., Qiu, H., Liu, S., & Liu, L. (2024). Evaluation of CO 2 removal rate of ECCO 2 R for a renal replacement therapy platform in an experimental setting. Artificial Organs. https://doi.org/10.1111/aor.14718

Vancouver

Qian Z, He H, Wang Y, Geng S, Li Y, Yuan X, et al. Evaluation of CO 2 removal rate of ECCO 2 R for a renal replacement therapy platform in an experimental setting. Artificial Organs. 2024. doi:10.1111/aor.14718

BibTeX
@article{Qian2024,
  author = {Qian, Zhicheng and He, Hao and Wang, Yuxuan and Geng, Shike and Li, Yang and Yuan, Xueyan and Zhang, Rui and Yang, Yi and Qiu, Haibo and Liu, Songqiao and Liu, Ling},
  title = {Evaluation of CO 2 removal rate of ECCO 2 R for a renal replacement therapy platform in an experimental setting},
  journal = {Artificial Organs},
  year = {2024},
  doi = {10.1111/aor.14718}
}
Kostenlos starten →